• McKesson’s FY27 second-quarter adjusted earnings per diluted share climbed 18% year over year to $11.68.
• A definitive agreement signed October 5 calls for investing approximately $1.4 billion for an approximately 49% minority interest in Option Care Health.
• The November 2 acquisition of Precision Medicine Group expanded capabilities in oncology, multispecialty and biopharma services.
• FY27 adjusted earnings per diluted share guidance rose to $45.6–$46.4 from $44.2–$45.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000927653-26-000279), on November 04, 2026, and is solely responsible for the information contained therein.